Mushroom Coffee: What Is It and Does It Actually Work?

Mushroom Coffee & Functional Beverages

80% less cordycepin in a manufactured Cordyceps coffee than in the raw mushroom

Song's 2020 lab analysis treated green coffee beans with mushroom extracts and measured the finished product. Cordycepin came in about 80% below the raw mushroom material, and beta-glucan 46-76% below, depending on which mushroom you compare against.

Song, Preventive Nutrition and Food Science, 2020

3,000mg

Lion's Mane per day used in the landmark MCI cognitive trial (Mori 2009)

2.03%

beta-glucan in the finished mushroom coffee vs. 3.79-8.57% in the raw mushrooms (Song 2020)

0

trials that have tested a commercial mushroom coffee, at a commercial serving size, against placebo

Song, Preventive Nutrition and Food Science, 2020

View as image ↗

Mushroom coffee has become a billion-dollar category built on a simple premise: if coffee is already a functional beverage, why not make it more functional? Add Lion's Mane for focus, Cordyceps for energy, Reishi for stress, Chaga for antioxidants. The idea makes intuitive sense. The chemistry is more complicated.

Start with the study that sits closest to the actual product. When Song's team analysed a finished Cordyceps coffee they had manufactured, approximately 80% of the cordycepin (one of Cordyceps' most biologically active compounds) had been lost compared to the raw mushroom material.^[3] Beta-glucan came in 46-76% lower, depending on which of the three raw mushrooms you measure against.

That finding doesn't mean mushroom coffee can't work. It means the question "does mushroom coffee work?" has a more nuanced answer than most coverage gives it. The mushroom science is real. The gaps between that science and what's in a commercial cup — dose, processing, extraction solvent, and even which species is in the blend — are also real.

What Mushroom Coffee Actually Is

Mushroom coffee is regular coffee (or a coffee substitute blend) combined with dried extracts from medicinal mushrooms. Most products use one or more of four mushrooms: Lion's Mane (Hericium erinaceus), Cordyceps (typically Cordyceps militaris), Reishi (Ganoderma lucidum), and Chaga (Inonotus obliquus).

The coffee and mushroom extract are usually sold as a pre-blended powder. Some products replace a portion of the coffee with other functional ingredients like cacao or ashwagandha. Others are pure coffee with mushroom extract added. Caffeine levels vary: some products use full-strength coffee, others use half-caf or decaf, and MUD/WTR uses masala chai as the caffeine base rather than coffee.

How much mushroom is in a serving is harder to state than the category's marketing implies. Where brands publish a per-serving figure, it typically lands in the low hundreds of milligrams. But many use proprietary blends that give a combined total across several species, or no figure at all, which makes the honest answer for a large share of the market "not disclosed." That matters before looking at any of the clinical evidence, because the trials that produced meaningful effects generally used doses measured in grams.

The functional beverage category that mushroom coffee belongs to has grown quickly, and a 2025 review of medicinal mushrooms in functional foods and nutraceuticals gives it particular attention, covering the pharmacology, the biotechnology of cultivation, and the rapidly growing market for mushroom-based beverages.^[1] What that review documents is a market and a body of pharmacological interest — not evidence that any particular beverage on the shelf delivers a clinical outcome.

For a direct look at how product doses compare to clinical trial doses, see Do Mushroom Coffee Products Have Enough Mushroom to Matter?.

The Processing Problem: What Coffee Heat Does to Mushroom Bioactives

Song 2020 sits closer to the actual product than any other published analysis, which makes it the most directly relevant study to whether mushroom coffee delivers what it claims. Song's team developed a functional Cordyceps coffee by treating green coffee beans with extracts of Cordyceps militaris, Phellinus linteus, and Inonotus obliquus (Chaga), then analysed the finished product.^[3]

The Closest Thing To A Mushroom Coffee Analysis

Song et al. (2020) · Preventive Nutrition and Food Science

Population

Laboratory product chemistry — no human participants and no health endpoint

Intervention

Green coffee beans treated with mixed extracts of Cordyceps militaris, Phellinus linteus and Inonotus obliquus, processed into a finished coffee

Comparator

The raw mushroom materials, and a control coffee with no mushroom treatment

Finding

Cordycepin measured 2,274.70 mg/kg in the finished coffee versus 11,533.22 mg/kg in the raw Cordyceps, a fall of about 80%. Beta-glucan was 2.03% in the coffee versus 3.79% (Cordyceps), 7.06% (Phellinus) and 8.57% (Chaga) in the raw mushrooms. Polyphenols were higher in the finished coffee (37.34 mg GAE/g) than in the raw mushrooms (23.17 mg GAE/g) — but the plain control coffee already measured 27.00 mg GAE/g.

mixed The compounds survive in measurable quantities; most of the original amount does not. Note this was a manufactured bean-infusion product, not a test of stirring extract powder into a brewed cup, and no health outcome was measured.

Song et al., Preventive Nutrition and Food Science, 2020; 25(2):184-193

The polyphenol result is worth reading carefully, because it is easy to over-read. Polyphenol content in the finished coffee (37.34 mg GAE/g) was indeed higher than in the raw mushroom material (23.17 mg GAE/g). But the plain control coffee, with no mushrooms involved at all, already measured 27.00 mg GAE/g. The same pattern held for antioxidant activity: control coffee scored 80.56% on DPPH radical scavenging, the Cordyceps coffee 82.21%, and the raw Cordyceps mushrooms only 62.89%. In other words, most of the polyphenol content and most of the antioxidant activity in a cup of mushroom coffee is coming from the coffee. That is a real benefit — but it is one you get from coffee.

There is also a limit on how far Song's loss figures generalise. Song made the product by infusing green beans before processing, which subjects the mushroom compounds to the full thermal history of coffee production. Many commercial mushroom coffees instead blend a dried mushroom extract powder into coffee that has already been roasted or made instant. That is a genuinely different process, and Song did not measure it. The honest reading is that Song establishes large losses are possible in a bean-infused product, not that every mushroom coffee on the shelf has lost 80% of its cordycepin.

Kała and colleagues took a complementary approach in 2024, preparing machine-brewed, instant, and traditionally brewed coffee with added Cordyceps militaris and Hericium erinaceus fruiting bodies, then analysing what ended up in the drink.^[2] What the mushrooms measurably contributed was minerals and phenolic acids: C. militaris was the better additional source of magnesium, zinc, copper, sodium, potassium and calcium, H. erinaceus contributed slightly more iron, and adding C. militaris raised 4-feruloylquinic acid to 18.6 mg per 200 mL and 3,5-di-caffeoylquinic acid to 3.76 mg per 200 mL. Notably, the compounds the category actually markets — cordycepin, hericenones, erinacines — are not what this analysis found the mushroom addition contributing.

The mechanism behind the losses is partly chemical: cordycepin is sensitive to heat and to the acidic environment of coffee brewing. Beta-glucan, a large polysaccharide chain, may also be partially broken down or bound to other compounds during processing. Hot water extraction (95-96°C for most coffee) also misses fat-soluble triterpenoid compounds, which require an alcohol solvent to extract.

Beyond Dose · What Was Actually Tested

The Preparation Studied Is Rarely The Preparation Sold

Dose is the usual criticism of mushroom coffee. It is not the only one. Solvent, mushroom part and delivery format decide which compounds reach you — and on each of those, the studies and the products diverge.

The retention figures for cordycepin and beta-glucan in "mushroom coffee"Song 2020 · ref 3

What was tested

Green coffee beans treated with mixed extracts of C. militaris, Phellinus linteus and Chaga, then processed into a finished coffee

What a cup actually is

Most products blend a dried mushroom extract powder with already-roasted or instant coffee — a different process, which Song did not measure

The one immune result from an actual beverageOntawong 2024 · ref 6

What was tested

A beverage made by submerged fermentation of C. militaris, standardised to 2.85 mg cordycepin per serving, 8 weeks, 10 men and 10 women

What a cup actually is

Extract powder rather than a fermentation broth, and virtually no product states a cordycepin figure you could line up against 2.85 mg

Reishi's sleep-promoting mechanismYao 2021 · ref 12

What was tested

The acidic fraction of an alcohol extract of G. lucidum mycelia, 25-100 mg/kg for 28 days, in mice with gut microbiota intact

What a cup actually is

Hot water extraction does not carry the alcohol-soluble fraction, and the mechanism has not been shown in humans at all

Lion's Mane cognitive improvement in mild cognitive impairmentMori 2009 · ref 7

What was tested

3 g/day of 96% Hericium erinaceus dry powder, in tablets, three times daily for 16 continuous weeks

What a cup actually is

A single daily serving containing a fraction of that amount, alongside three other species

What happens when the dose gap is closedSurendran 2025 · ref 5

What was tested

3 g of a 10:1 Hericium erinaceus fruiting-body extract, acute, randomised crossover in 18 healthy adults

What a cup actually is

No composite cognition or mood benefit was found even at this dose — so dose alone does not explain the category’s results

For a deeper look at why extraction method matters for which compounds make it into your cup, see Double-Extraction Mushroom Tinctures: Why Alcohol + Water Captures More Compounds.

Lion's Mane and Cognition: The Evidence Behind the Most Popular Claim

Lion's Mane is the mushroom most commonly associated with cognitive benefits, and it appears in more mushroom coffee products than any other species. The evidence behind its cognitive effects is among the most developed in the medicinal mushroom field — and also among the most frequently overstated.

The landmark trial was published by Mori and colleagues in 2009.^[7] Mori enrolled 30 Japanese adults aged 50-80 with mild cognitive impairment in a double-blind, placebo-controlled study. The treatment group took four 250mg tablets, containing 96% Lion's Mane dry powder, three times a day — 3,000mg daily — for 16 weeks. Scores on a cognitive scale based on the Revised Hasegawa Dementia Scale were significantly higher in the Lion's Mane group than in placebo at weeks 8, 12, and 16. Four weeks after the supplement stopped, scores fell significantly, suggesting the benefit required continued use.

Two features of that trial travel poorly to a coffee cup: the dose was 3g per day, and it was sustained for 16 weeks in people who already had measurable cognitive impairment.

More recent trials have tested younger, healthy adults. Docherty and colleagues published a pilot RCT in 2023 in 41 healthy adults aged 18-45, using 1.8g of Hericium erinaceus per day.^[8] After a single dose, participants were faster on the Stroop task at 60 minutes (p=0.005). After 28 days, reduced subjective stress was only a trend (p=0.051). The authors were explicit that null and limited negative findings also appeared, and that the small sample means the results should be read with caution.

Surendran and colleagues published an acute crossover RCT in 2025 in 18 healthy adults aged 18-35, using 3g of a 10:1 Lion's Mane fruiting body extract.^[5] This trial is often cited as further evidence that Lion's Mane sharpens cognition. It found the opposite on its pre-specified outcomes: no significant effect on composite measures of global cognitive function or mood at 90 minutes. Of the individual tests spanning executive function, working memory, psychomotor skills, attention and processing speed, only the pegboard test improved.

That result matters more than its sample size suggests, because it partly decouples two arguments. A 10:1 extract at 3g is an enormous dose by commercial standards — far beyond anything a serving of mushroom coffee delivers. If under-dosing were the only obstacle, this trial should have shown a clear acute effect. It did not.

A 2025 systematic review by Menon and colleagues, registered on PROSPERO and conducted to PRISMA guidelines, searched the clinical literature on Lion's Mane with the stated aim of establishing a safety profile.^[14] It identified five randomised controlled trials alongside laboratory studies, pilot trials, a cohort study and a case report — a real but still thin clinical base, with the most consistent cognitive signals in populations that already have cognitive decline.

The primary active compounds credited for Lion's Mane's brain effects are hericenones (found in the fruiting body) and erinacines (found in the mycelium), both linked to nerve growth factor. For a detailed explanation of these compounds, see Hericenones and Erinacines: Lion's Mane's Brain-Boosting Compounds.

Dose Comparison

Lion's Mane (Hericium erinaceus): Research vs. commercial doses

What research used

1,800-3,000 mg per day of powder, or 3,000 mg of a 10:1 extract acutely

Oral tablets, capsules or powder

Daily, usually divided across three doses · Single acute dose up to 16 continuous weeks

Mori 2009 used 3 g/day for 16 weeks in adults with mild cognitive impairment and found significant gains. Docherty 2023 used 1.8 g/day in healthy young adults with mixed results. Surendran 2025 used 3 g of a 10:1 extract acutely and found no effect on composite cognition or mood.

What supplements sell

Typically low hundreds of milligrams per serving where disclosed, often shared across several species

Dried extract powder dissolved in hot water with coffee

Usually one serving per day

Blended mushroom coffees, frequently using proprietary blends that do not break the total down by species

A commercial serving sits well below every dose that produced a positive cognitive result, and the extract type is usually unspecified. But the gap is not the whole explanation: the largest acute dose tested, 3 g of a 10:1 extract, missed its primary outcome too.

• *Extract ratio and solvent are rarely stated, so milligram comparisons between a product and a trial are approximate at best.
• *Fruiting body and mycelium contain different compounds — hericenones and erinacines respectively — and many products do not specify which they use.
• *Mori's positive result was in adults with existing mild cognitive impairment, not healthy adults seeking sharper focus.

Refs 5, 7, 8, 14

Cordyceps and Energy: A Species Problem Underneath the Performance Claim

Cordyceps is the mushroom most associated with energy and athletic performance. The evidence is more mixed than product marketing suggests — and the most important complication is which species was actually studied.

Hirsch and colleagues published a randomised, double-blind, placebo-controlled trial in 2017 that is routinely cited as the human evidence for Cordyceps militaris and exercise.^[9] Two details are usually dropped. First, the intervention was a mushroom blend containing C. militaris at 4g per day, not C. militaris alone, so any effect cannot be attributed to Cordyceps specifically. Second, after one week of supplementation in 28 participants there was no significant time-by-treatment interaction on VO2max, ventilatory threshold, time to exhaustion, peak power, average power or percent drop. Only 10 volunteers continued for a further two weeks, and it was in that small subgroup that VO2max improved significantly (p=0.042, +4.8 ml/kg/min).

Parcell and colleagues, publishing in 2004, tested Cordyceps sinensis (sold as CordyMax Cs-4) at 3g per day for five weeks in 22 endurance-trained male cyclists and found no improvement in VO2peak, ventilatory threshold, or time-trial performance compared to placebo.^[10] A well-conducted null result at a dose ten times what a cup provides.

Then the picture inverts. A 2025 meta-analysis by Shu and colleagues pooled 14 randomised controlled trials involving 528 athletes, with eight studies (n=288) entering quantitative synthesis.^[11] It found that Cordyceps sinensis supplementation significantly improved endurance performance (p=0.05), ventilatory threshold (p=0.03) and VO2peak (p=0.04), with low heterogeneity. Ganoderma lucidum, separately, reduced blood urea nitrogen and raised haemoglobin.

The clinical evidence closest to mushroom coffee itself comes from Ontawong and colleagues' 2024 randomised controlled trial.^[6] This is the only published trial that used an actual beverage rather than capsules. It is a genuinely interesting result, and also a small one.

The Only Beverage Trial

Ontawong et al. (2024) · Scientific Reports

Population

Healthy adult volunteers in Phayao Province, Thailand — 10 men and 10 women

Intervention

A functional beverage produced by submerged fermentation of Cordyceps militaris, containing 2.85 mg of cordycepin, for 8 weeks

Comparator

Matched placebo beverage

Finding

Natural killer cell activity increased in the male group from baseline at 4 weeks (p=0.049), and in women receiving the beverage for 8 weeks the increase from baseline was significant versus placebo (p=0.023). Immunoglobulins and safety parameters were also assessed.

preliminary Twenty participants split by sex means each analysis rests on ten people. The beverage was fermentation-derived and standardised on cordycepin — not the dried extract blend used in commercial mushroom coffee — and immune marker shifts are not the same as a health outcome.

Ontawong et al., Scientific Reports, 2024; 14(1):7994

It is worth noting what this trial does not show. It does not show that the dose was larger than commercial products: 2.85mg of cordycepin is a small absolute quantity, and because virtually no mushroom coffee discloses a cordycepin figure, the two cannot be lined up. If anything, Ontawong is a reminder that a modest, well-characterised dose in a beverage can move a biomarker — which cuts against a purely dose-based dismissal of the category.

Reishi: What the Stress Claim Rests On

Reishi (Ganoderma lucidum) appears in several mushroom coffee products marketed around stress reduction and mental calm. The human trial most often cited for this is worth reading closely, because what it measured is not quite what the marketing claims.

Mitra and colleagues published a double-blind, randomised, placebo-controlled trial in 2024 in 78 sedentary female college students, randomised to 500mg of Reishi daily, 1000mg daily, or placebo, assessed over 30 days.^[13] Anthropometric, psychological, physiological and physical fitness parameters were all measured. The significant between-group improvements reported were heart rate, maximal oxygen consumption, physical work capacity (PWC170) and right-hand grip strength — and they appeared in the 1000mg group. The 500mg group did not separate from placebo on those outcomes.

So the strongest human Reishi trial in this cluster demonstrates cardiovascular and fitness effects at 1000mg per day, not a measured reduction in stress markers. It also provides a dose-response signal that is directly relevant here: half the dose produced no measurable separation, and 500mg of a single species is already at or above what many mushroom coffees provide across their entire blend.

The calming mechanism usually attributed to Reishi comes from animal work. Yao and colleagues published a 2021 study in mice showing that Reishi promotes sleep through a gut microbiota-dependent, serotonin-associated pathway.^[12] Mice given 25, 50 or 100 mg/kg for 28 days fell asleep faster and slept longer; levels of the sleep-promoting neurotransmitter 5-hydroxytryptamine rose in the hypothalamus; and when the gut microbiota was depleted with antibiotics, the sleep effect disappeared entirely — strong evidence that the pathway runs through gut bacteria.

Two caveats keep this from transferring to a coffee cup. It is a mouse study. And the preparation was the acidic fraction of an alcohol extract of Reishi mycelia — a fraction that hot-water coffee brewing would largely fail to deliver.

That second point defuses a tension often raised about these products: that combining a sedative mushroom with caffeine is pharmacologically contradictory. Caffeine promotes wakefulness by blocking adenosine receptors. Reishi's sedative pathway, as demonstrated, runs through serotonin and gut bacteria. They are different mechanisms pointing in different directions — but the Reishi side of that contradiction has only been shown in mice, using an extract type that a hot-water beverage does not produce. It is a framing curiosity rather than a demonstrated conflict, and it is not a safety concern.

Chaga: Thin Benefit Evidence, Real Human Harm Reports

Chaga (Inonotus obliquus) is included in mushroom coffee products for its antioxidant properties. A 2023 review by Fordjour and colleagues surveyed Chaga's mycochemistry and reported bioactivities — antioxidant, anti-inflammatory, antiviral and antitumor — drawn from laboratory and animal research, alongside its traditional uses and potential applications in pharmaceuticals, food, cosmetics and agriculture.^[15] What that review does not contain is a human efficacy trial supporting the antioxidant benefit as sold.

The human literature that does exist for Chaga is mostly about harm, and it is specific. Chaga is exceptionally high in oxalate — the workup in one case report measured the powder at 14.2g per 100g, far above the oxalate-rich foods usually flagged in kidney-stone advice.^[17] Oxalic acid binds calcium and can deposit in the kidneys as calcium oxalate crystals.

Three published case reports connect sustained Chaga intake to kidney injury. The first, in 2014, described a 72-year-old Japanese woman who took 4-5 teaspoons of Chaga powder daily for six months after a liver cancer diagnosis; her renal function declined, haemodialysis was started, and biopsy showed diffuse tubular atrophy with oxalate crystals in the tubules.^[16] In 2020, a 49-year-old Korean man reached end-stage renal disease after years of Chaga powder taken for atopic dermatitis, with biopsy showing chronic tubulointerstitial nephritis and oxalate deposits; his estimated daily oxalate intake ran two to five times a usual diet.^[17] In 2022, a 69-year-old man taking 10-15g of Chaga powder daily plus 500mg of vitamin C for three months developed acute kidney injury presenting as nephrotic syndrome.^[18]

A 2026 rat study tested this directly, dosing animals at levels extrapolated from one of those clinical cases.^[19] The high-dose group (3,844.8 mg/kg body weight, equivalent to 549 mg/kg of oxalate) showed oxalate crystal deposition, tubular injury, raised urinary protein and elevated oxidative stress markers. The standard-dose group did not show the same injury — which is the useful part of the finding, because it indicates the effect is dose-dependent rather than intrinsic to any Chaga exposure.

The dose context matters enormously for a mushroom coffee drinker. Every human case involved grams per day — 4-5 teaspoons, 10-15g — sustained for months or years. A mushroom coffee serving typically contains a few hundred milligrams across all its species combined, one to two orders of magnitude below the exposures in these reports.

Safety

Moderate

Chaga's oxalate load is the one clearly documented harm in this category

Concern

Chaga is exceptionally oxalate-dense (measured at 14.2 g per 100 g in one case workup). Three published case reports link sustained gram-level daily intake to oxalate nephropathy, including one progression to end-stage renal disease, and a 2026 rat model reproduced dose-dependent kidney injury at high doses.

What the research says

Those cases involved grams of Chaga powder per day for months to years — roughly one to two orders of magnitude above a typical mushroom coffee serving. For a healthy adult drinking one cup a day, the documented risk does not translate directly. The exposure that matters is cumulative and dose-dependent, so daily long-term use sits differently from occasional use.

Particularly relevant for: People with a history of kidney stones, reduced kidney function, or an already oxalate-heavy diet (spinach, almonds, rhubarb, certain legumes) should be most cautious, and should account for Chaga alongside other oxalate sources. Combining Chaga with high-dose vitamin C, as in the 2022 case, adds to oxalate load. People who are pregnant or breastfeeding, immunocompromised, or taking immunosuppressants or anticoagulants should speak to a clinician before using concentrated mushroom extracts.

What to do

This article is research analysis, not medical advice. Discuss supplement use with a qualified healthcare professional, particularly if you take prescription medication or have an existing health condition.

Refs 15, 16, 17, 18, 19

The Trials Closest to an Actual Mushroom Coffee Study

Most of the human evidence for these mushrooms comes from capsule or powder supplementation trials. Two studies come closer to the real-world format, and neither closes the gap.

Ontawong's 2024 Cordyceps militaris beverage trial, described above, is the only published trial that tested a mushroom drink on human health outcomes.^[6] The beverage format mirrors what mushroom coffee consumers actually do — but the drink was fermentation-derived rather than an extract blend, the endpoint was immune markers rather than the focus and energy the category sells, and the sample was 20 people.

Hisamuddin and colleagues published a randomised, double-blind, placebo-controlled trial in 2026 testing a mushroom blend supplement on stress, fatigue and sleep.^[4] Fifty participants received either the commercial product Restake or placebo, assessed at baseline, 6 weeks and 12 weeks with validated instruments. Anxiety fell on both the STAI-S and HAM-A at 6 and 12 weeks, depression scores fell on the BDI, general, physical and mental fatigue all improved, and sleep quality scores improved on the PSQI. Serum cortisol and ACTH dropped significantly, with reductions in CRP and norepinephrine.

That is a substantive result, and it is the closest thing the category has to evidence for its adaptogenic positioning: a multi-mushroom blend, humans, placebo control, biomarkers alongside questionnaires. Its limits are equally clear. It tests one specific commercial formulation at that product's own dose, in 50 people, over 12 weeks — not mushroom coffee, and not a generic conclusion about mushroom blends.

Four Mushrooms · Four Different Evidence Bases

The Cup Is Sold As One Product. The Evidence Is Not One Body.

Each species is in the blend for a different marketed reason, and each reason has climbed a different distance up the evidence hierarchy. None of the four has been tested as mushroom coffee, at a mushroom coffee dose.

Lion's ManeHericium erinaceusSold for: Focus and cognition

Small human trials — mixed

Best human evidence

Mori 2009 (n=30, adults 50-80 with mild cognitive impairment, 3 g/day for 16 weeks) found significantly higher cognitive scores at weeks 8, 12 and 16.

What it does not carry

In healthy young adults the picture is weaker: Docherty 2023 (n=41, 1.8 g/day) found faster Stroop responses acutely but only a trend on stress, and Surendran 2025 (n=18) found no effect on composite cognition or mood — at 3 g of a 10:1 extract.

CordycepsC. militaris / C. sinensisSold for: Energy and performance

Meta-analysis — but on the other species

Best human evidence

Shu 2025 pooled 14 RCTs in 528 athletes and found Cordyceps sinensis improved endurance performance, ventilatory threshold and VO2peak.

What it does not carry

The pooled ergogenic signal belongs to C. sinensis. Consumer products almost always contain C. militaris, whose human evidence here is one 4 g/day blend trial in which only 10 people reached the 3-week timepoint — and Parcell 2004 found no effect from 3 g/day of a sinensis product in 22 trained cyclists.

ReishiGanoderma lucidumSold for: Stress and calm

Small human trial — different endpoints

Best human evidence

Mitra 2024 randomised 78 sedentary female college students to 500 mg, 1000 mg or placebo for 30 days.

What it does not carry

The significant between-group effects reported were heart rate, VO2max, physical work capacity and grip strength in the 1000 mg group — cardiovascular and fitness measures, not stress markers. The 500 mg arm did not separate from placebo. The sleep mechanism often quoted for Reishi comes from mice given an alcohol extract of mycelia.

ChagaInonotus obliquusSold for: Antioxidants

Preclinical only — while harm evidence is human

Best human evidence

Fordjour 2023 reviews antioxidant, anti-inflammatory, antiviral and antitumor activity from laboratory and animal work.

What it does not carry

No human efficacy trial supports the antioxidant claim as sold. Meanwhile the human literature that does exist for Chaga is three published case reports of oxalate nephropathy, all at intakes of grams per day sustained for months to years.

Does Mushroom Coffee Work? An Honest Assessment

The evidence for the individual mushrooms is real, but it is more uneven than the shelf suggests. Lion's Mane has a positive double-blind trial in adults with mild cognitive impairment and a primary-null acute trial in healthy young adults. Cordyceps has meta-analytic support — for the species most products don't use. Reishi has a small trial demonstrating fitness and cardiovascular effects at 1000mg. Chaga has laboratory antioxidant data and three human case reports of kidney injury.

Four factors sit between that literature and a cup:

Processing degrades key bioactives. Song 2020 measured roughly 80% less cordycepin and 46-76% less beta-glucan in a manufactured mushroom coffee than in the raw material — though in a bean-infusion product that may not represent every manufacturing route.^[3]

Doses are far lower than trial doses. The landmark Lion's Mane trial used 3,000mg per day for 16 weeks.^[7] A commercial serving delivers a fraction of that, frequently split across several species.

But dose alone doesn't explain the results. Surendran 2025 gave 3g of a 10:1 extract and still found no effect on composite cognition or mood.^[5] Closing the dose gap would make a cup a fairer test of the ingredient; it would not guarantee an effect.

Preparation and species are usually unspecified. Fruiting body or mycelium, water or alcohol extraction, militaris or sinensis, and the extract ratio all change what arrives in the cup — and most labels answer none of these questions.

Mushroom Coffee As A Product Category

1. Product and compound chemistrycompleted

   Song 2020 quantified cordycepin, beta-glucan and polyphenols in a manufactured Cordyceps coffee; Kala 2024 quantified bioelements and chlorogenic acids in coffee brewed with C. militaris and H. erinaceus fruiting bodies. Measurable compounds are present. Refs 2, 3.

2. Mechanistic and animal work on the ingredientscompleted

   Yao 2021 established a gut-microbiota-dependent, serotonin-associated sleep pathway for a Reishi alcohol-extract fraction in mice, abolished by antibiotic depletion. Lee 2026 modelled Chaga oxalate kidney injury in rats. Refs 12, 19.

3. Small human trials of the isolated ingredientscurrent

   Mori 2009 (n=30, MCI, positive), Docherty 2023 (n=41, mixed), Surendran 2025 (n=18, primary outcome null), Parcell 2004 (n=22, null), Hirsch 2017 (n=28, 3-week arm n=10), Mitra 2024 (n=78, fitness endpoints), Ontawong 2024 (n=20, beverage, immune markers), Hisamuddin 2026 (n=50, blend, stress and sleep). Refs 4, 5, 6, 7, 8, 9, 10, 13.

4. Adequately powered RCT of mushroom coffee at a commercial servingmissing

   No trial has given people a commercially representative mushroom coffee, at a commercial serving size, and measured a cognitive, energetic or immune endpoint against placebo. This is the step that would move the category claim from plausible to demonstrated.

5. Meta-analysis of mushroom coffee outcomesmissing

   Not possible without the trials above. Shu 2025 pools fungal supplementation trials in athletes, not mushroom coffee products, and its ergogenic finding attaches to C. sinensis rather than the C. militaris in consumer products. Ref 11.

The chemistry is established and the ingredient trials are underway and mixed. The specific claim being sold — that this product, at this serving, does something measurable — has never been directly tested. That is not the same as being disproven, but it is a long way from proven.

Refs 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 19

Fact Check

'Mushroom coffee gives you the benefits of the mushrooms'

The claim

“Because mushroom coffee contains Lion's Mane, Cordyceps, Reishi and Chaga, drinking it delivers the cognitive, energy, stress and antioxidant benefits those mushrooms have been studied for.”

Product marketing that cites ingredient-level research — real trials, accurately described — without noting the dose, preparation, species or population those trials used.

What research shows

Overstated

The trials cited used grams per day of specific preparations, sustained for weeks, usually in targeted populations. A serving of mushroom coffee delivers a fraction of that, in a different preparation, split across species. And the single largest acute dose tested in healthy young adults — 3 g of a 10:1 Lion's Mane extract — produced no significant effect on composite cognition or mood.

This is not evidence that mushroom coffee does nothing. It is evidence that the inference from 'the mushroom has been studied' to 'the drink delivers the finding' has not been tested. Ontawong 2024 shows a modest, well-characterised dose in a beverage can shift a biomarker, and Hisamuddin 2026 shows a commercial mushroom blend can move stress, fatigue and sleep measures over 12 weeks. Neither trial used mushroom coffee.

Refs 4, 5, 6, 7, 8

What mushroom coffee reliably offers over straight coffee remains unclear from the clinical literature. The honest answer is that it depends on which mushrooms are included, at what dose, using what extraction method and which species, and whether the processing preserved the relevant compounds. Some products may deliver meaningful amounts of well-studied mushrooms. Many probably don't. As a drink, it is a low-risk choice for most healthy adults; as a substitute for evaluating or treating a cognitive, energy or immune problem, it is not supported by evidence.

For detailed brand-by-brand evaluation, see MUD/WTR, Ryze, and Four Sigmatic: Mushroom Coffee Compared and Best Mushroom Coffee Brands: A Science-Based Review.

For consumers specifically interested in cognitive support from Lion's Mane, understanding the difference between fruiting body and mycelium preparations is a more important variable than the beverage format. See Fruiting Body vs. Mycelium: The Great Mushroom Supplement Debate.

For a broader comparison of mushroom beverage formats, including mushroom matcha and tea alternatives to coffee, see Mushroom Matcha and Tea: Functional Beverages Beyond Coffee.

The Bottom Line

The mushrooms in mushroom coffee have genuine clinical evidence behind them, but that evidence comes from high-dose capsule, powder and standardised-extract trials rather than from studies of coffee-format products. The only direct analysis of a manufactured mushroom coffee (Song 2020) found roughly 80% less cordycepin and 46-76% less beta-glucan than the raw mushrooms, while most of the polyphenol content in the cup traced to the coffee itself. Commercial servings are typically in the low hundreds of milligrams where disclosed, far below trial doses — though Surendran 2025 showed that even 3g of a 10:1 Lion's Mane extract failed to move composite cognition acutely, so dose is not the only variable. The clearest safety consideration is Chaga's oxalate content, documented in three human case reports of kidney injury at gram-level daily intakes far above a coffee serving. No trial has yet tested a commercial mushroom coffee at a commercial serving size against placebo.

Frequently Asked Questions

What is mushroom coffee made of?

Mushroom coffee is regular coffee (or a coffee substitute blend) combined with dried medicinal mushroom extracts. The most common mushrooms used are Lion's Mane (Hericium erinaceus), Cordyceps (usually Cordyceps militaris), Reishi (Ganoderma lucidum), and Chaga (Inonotus obliquus). Products are typically sold as a pre-blended powder that dissolves in hot water like instant coffee, though some brands sell mushroom extract packets to add to regular brewed coffee. Where brands publish a per-serving amount it is usually in the low hundreds of milligrams, but many use proprietary blends that give only a combined total across species, or no figure at all.

Does mushroom coffee actually work?

The individual mushrooms have genuine human trial evidence, but it is uneven. Lion's Mane improved cognitive scores in adults with mild cognitive impairment at 3g/day for 16 weeks (Mori 2009), yet an acute 3g dose of a 10:1 extract produced no effect on composite cognition or mood in healthy young adults (Surendran 2025). A 2025 meta-analysis found ergogenic benefits for Cordyceps sinensis — the species most products don't contain. Reishi's strongest trial (Mitra 2024) demonstrated cardiovascular and fitness improvements at 1000mg/day, not stress markers. Song's 2020 analysis of a manufactured mushroom coffee found roughly 80% less cordycepin and 46-76% less beta-glucan than raw mushrooms. No trial has tested a commercial mushroom coffee at a commercial serving against placebo, so the category is best described as unproven rather than disproven.

Is mushroom coffee safe to drink every day?

For most healthy adults, daily mushroom coffee made with standard commercial products is unlikely to cause harm. The clearest safety consideration is Chaga, which is exceptionally high in oxalate — measured at 14.2g per 100g in one case workup. Three published case reports link sustained Chaga intake to oxalate nephropathy, including one progression to end-stage renal disease, and a 2026 rat model reproduced dose-dependent kidney injury. Those cases all involved grams of Chaga powder daily for months to years, one to two orders of magnitude above a typical serving. People with a history of kidney stones or reduced kidney function, those on an already oxalate-heavy diet, those taking immunosuppressants (Reishi may interact), and those pregnant or breastfeeding should check with a healthcare provider before regular use. This article is research analysis, not medical advice.

What mushrooms are in mushroom coffee?

The four mushrooms most commonly found in mushroom coffee products are Lion's Mane (Hericium erinaceus), Cordyceps militaris, Reishi (Ganoderma lucidum), and Chaga (Inonotus obliquus). Some products use Turkey Tail (Trametes versicolor) or ashwagandha (technically a root, not a mushroom) in blends marketed for immune support. MUD/WTR includes Lion's Mane, Chaga, Reishi, and Turkey Tail. Ryze uses a multi-species proprietary blend that does not disclose per-species doses. Four Sigmatic's coffee products often focus on Lion's Mane and Chaga. For a brand-by-brand breakdown, see the dedicated comparison article in this cluster.

Does mushroom coffee have caffeine?

Most mushroom coffee products contain caffeine, because they use regular coffee as their base. The caffeine amount varies: some products are full-strength coffee blended with mushroom extract, others use half-caf or decaf coffee, and some use non-coffee caffeine sources like masala chai (MUD/WTR uses this approach). There are also caffeine-free mushroom "coffee" products that use mushroom extract with other adaptogens but no coffee at all. If caffeine content matters to you, check the specific product, because there is no standard across the category.

Does the Reishi in mushroom coffee cancel out the caffeine?

There is no human evidence that it does. Reishi's sleep-promoting effect was demonstrated in mice, using the acidic fraction of an alcohol extract of Reishi mycelia, and the effect disappeared when the animals' gut bacteria were depleted (Yao 2021). Caffeine promotes wakefulness by a different route, blocking adenosine receptors. So the two act through separate mechanisms pointing in opposite directions in principle — but the Reishi side has only been shown in mice, using an extract type that hot-water brewing would not deliver into a cup. It is a pharmacological curiosity rather than a demonstrated conflict, and it is not a safety concern.

What does mushroom coffee taste like?

Most mushroom coffee products taste primarily like coffee, with earthy undertones from the mushroom extracts. The mushroom flavor is generally mild; in most products, you'd only notice it if you were looking for it. Reishi adds a slight bitterness, Chaga contributes a more pronounced earthy flavor, and Lion's Mane is relatively neutral. Products that use cacao or masala chai as a base instead of coffee have a distinctly different flavor profile, more similar to hot chocolate or spiced tea than traditional coffee. Song's 2020 flavor-pattern analysis found that a mushroom-treated coffee retained the original coffee aroma without the mushroom off-flavor carrying through.

Sources & References

1. 1RTHM-02215·Yang, Jing-Ya et al. (2025). “Innovative applications of medicinal mushrooms in functional foods and nutraceuticals: a focus on health-boosting beverages..” Frontiers in cellular and infection microbiology.Study breakdown →PubMed →↩
2. 2RTHM-00882·Kała, Katarzyna et al. (2024). “Coffee with Cordyceps militaris and Hericium erinaceus Fruiting Bodies as a Source of Essential Bioactive Substances..” Pharmaceuticals (Basel.Study breakdown →PubMed →↩
3. 3RTHM-00656·Song, Hyo-Nam (2020). “Functional Cordyceps Coffee Containing Cordycepin and β-Glucan..” Preventive nutrition and food science.Study breakdown →PubMed →↩
4. 4RTHM-00959·Hisamuddin, Ahmad Safiyyu'd-Din et al. (2026). “Adaptogenic Effects of Mushroom Blend Supplementation on Stress, Fatigue, and Sleep: A Randomised, Double-Blind, and Placebo-Controlled Trial..” Brain and behavior.Study breakdown →PubMed →↩
5. 5RTHM-00952·Surendran, Geyan et al. (2025). “Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study..” Frontiers in nutrition.Study breakdown →PubMed →↩
6. 6RTHM-00899·Ontawong, Atcharaporn et al. (2024). “A randomized controlled clinical trial examining the effects of Cordyceps militaris beverage on the immune response in healthy adults..” Scientific reports.Study breakdown →PubMed →↩
7. 7RTHM-00165·Mori, Koichiro et al. (2009). “Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial..” Phytotherapy research : PTR.Study breakdown →PubMed →↩
8. 8RTHM-00821·Docherty, Sarah et al. (2023). “The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study..” Nutrients.Study breakdown →PubMed →↩
9. 9RTHM-00473·Hirsch, Katie R et al. (2017). “Cordyceps militaris Improves Tolerance to High-Intensity Exercise After Acute and Chronic Supplementation..” Journal of dietary supplements.Study breakdown →PubMed →↩
10. 10RTHM-00075·Parcell, Allen C et al. (2004). “Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance..” International journal of sport nutrition and exercise metabolism.Study breakdown →PubMed →↩
11. 11RTHM-00951·Shu, Meng-Yuan et al. (2025). “Effects of fungal supplementation on endurance, immune function, and hematological profiles in adult athletes: a systematic review and meta-analysis..” Frontiers in nutrition.Study breakdown →PubMed →↩
12. 12RTHM-00731·Yao, Chunyan et al. (2021). “Ganoderma lucidum promotes sleep through a gut microbiota-dependent and serotonin-involved pathway in mice..” Scientific reports.Study breakdown →PubMed →↩
13. 13RTHM-00895·Mitra, Sudeep et al. (2024). “Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Supplementation on Psychological Stress and Selective Fitness Profile Parameters in Female College Students in West Bengal, India..” International journal of medicinal mushrooms.Study breakdown →PubMed →↩
14. 14RTHM-00943·Menon, Arya et al. (2025). “Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review..” Frontiers in nutrition.Study breakdown →PubMed →↩
15. 15RTHM-01694·Fordjour, Eric et al. (2023). “Chaga mushroom: a super-fungus with countless facets and untapped potential..” Frontiers in pharmacology.Study breakdown →PubMed →↩
16. 16RTHM-00329·Kikuchi, Yuko et al. (2014). “Chaga mushroom-induced oxalate nephropathy..” Clinical nephrology.Study breakdown →PubMed →↩
17. 17RTHM-00630·Lee, Sua et al. (2020). “Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature..” Journal of Korean medical science.Study breakdown →PubMed →↩
18. 18RTHM-00775·Kwon, Ohyun et al. (2022). “Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report..” Medicine.Study breakdown →PubMed →↩
19. 19RTHM-02379·Lee, Sua et al. (2026). “Kidney Injury Induced by High-Dose Chaga Mushroom Consumption: Experimental Evidence in a Rat Model..” Journal of Korean medical science.Study breakdown →PubMed →↩